Last reviewed · How we verify

NCT02892227: JECICA

Management of Acute Heart Failure: Contribution of Ultrasound Daily "in Bed Patient" Adjustment on Therapy With Impact Measure on re Hospital Rate During 30 Days

Completed NA Last updated 12 March 2026
What this trial tests

NA trial testing Transmitral flow estimation in Heart Failure in 250 participants. Completed in 5 June 2019.

Timeline
15 November 2016
Primary endpoint
5 June 2019
5 June 2019

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment250
Start date15 November 2016
Primary completion5 June 2019
Estimated completion5 June 2019
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

Adults 18 to 90, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our hypothesis: a daily bedside echocardiographic assessment, protocolized, simple and reproducible estimation of filling pressures with an evaluation of mitral inflow and the inferior vena cava, allow a more reliable estimate of the true blood volume of the patient and thus lead to a therapeutic adjustment more suitable. This therapeutic adjustment closer to patient's needs would impact fewer readmissions at 30 days and mortality, less alteration of biological parameters myocardial, kidney and liver.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Ultrasound imaging of congestion in heart failure: examinations beyond the heart.
    Pellicori P, Platz E, Dauw J, Ter Maaten JM, et al · · 2021 · cited 136× · PMID 33118672 · DOI 10.1002/ejhf.2032
  2. New perspectives and future directions in the treatment of heart failure.
    Pellicori P, Khan MJI, Graham FJ, Cleland JGF. · · 2020 · cited 32× · PMID 31327116 · DOI 10.1007/s10741-019-09829-7
  3. Non-Invasive Assessment of Congestion by Cardiovascular and Pulmonary Ultrasound and Biomarkers in Heart Failure.
    Ilieșiu AM, Hodorogea AS, Balahura AM, Bădilă E. · · 2022 · cited 17× · PMID 35454010 · DOI 10.3390/diagnostics12040962
  4. Point of Care Ultrasound (POCUS) in the Management of Heart Failure: A Narrative Review.
    Naddaf N, Dianati Maleki N, Goldschmidt ME, Kalogeropoulos AP. · · 2024 · cited 7× · PMID 39064020 · DOI 10.3390/jpm14070766
  5. Impact of Daily Bedside Echocardiographic Assessment on Readmissions in Acute Heart Failure: A Randomized Clinical Trial.
    Ricci JE, Aguilhon S, Occean BV, Soullier C, et al · · 2022 · cited 3× · PMID 35407655 · DOI 10.3390/jcm11072047
  6. Management of acute heart failure: Contribution of daily bedside echocardiographic assessment on therapy adjustment with impact measure on the 30-day readmission rate (JECICA).
    Ricci JE, Kalmanovich E, Robert C, Chevallier T, et al · · 2018 · cited 1× · PMID 30364633 · DOI 10.1016/j.conctc.2018.07.006

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02892227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing